ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2023

The Effects of Switching from Dipeptidyl Peptidase-4 Inhibitors to Glucagon-Like Peptide-1 Receptor Agonists on Bone Mineral Density in Diabetic Patients.

Chun-Feng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.